Group 1 - The core viewpoint of the article highlights that Sanbo Brain Science's stock closed at 66.46 yuan, down 2.01%, with a rolling PE ratio of 124.57 times and a total market value of 13.69 billion yuan [1] - The average PE ratio for the medical services industry is 49.76 times, with a median of 64.18 times, placing Sanbo Brain Science at the 39th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders for Sanbo Brain Science increased to 37,673, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Sanbo Brain Science Hospital Management Group Co., Ltd. primarily engages in clinical medical services, with main products including medical services, pharmaceuticals, supply chain, and other businesses [1] - In the latest quarterly report for Q1 2025, the company achieved an operating income of 393 million yuan, a year-on-year increase of 16.78%, and a net profit of 38.31 million yuan, up 14.56%, with a gross profit margin of 26.44% [1]
三博脑科收盘下跌2.01%,滚动市盈率124.57倍,总市值136.90亿元